Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Active not recruiting 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Cognitive Dysfunction 2Breast Neoplasms 2Depression 1Breast Cancer Survivors 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 252Magnetic Resonance Spectroscopy 244Cyclophosphamide 240Cisplatin 213Paclitaxel 206Radiotherapy 195Biopsy 171Gemcitabine 155Dexamethasone 148durvalumab 143atezolizumab 126Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 111Radiation 109Docetaxel 103Pemetrexed 102Etoposide 101fludarabine 97venetoclax 95Fluorouracil 92Capecitabine 92Radiosurgery 90Prednisone 89Oxaliplatin 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Transcranial Direct Current Stimulation × 1 year × Clear all
NCT02726763 2026-04-27

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
18 enrolled
Breast

Breast Cancer Survivors

NCT07083518 2025-07-24

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors

Anhui Medical University

Phase NA Active not recruiting
60 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

NCT06053775 2025-07-20

ONCODEP

University of Santiago de Compostela

Phase NA Active not recruiting
82 enrolled
Breast

Breast Neoplasms, Depression, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡